Does EVOLOCUMAB Cause Intentional dose omission? 101 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 101 reports of Intentional dose omission have been filed in association with EVOLOCUMAB (REPATHA). This represents 0.1% of all adverse event reports for EVOLOCUMAB.
101
Reports of Intentional dose omission with EVOLOCUMAB
0.1%
of all EVOLOCUMAB reports
0
Deaths
20
Hospitalizations
How Dangerous Is Intentional dose omission From EVOLOCUMAB?
Of the 101 reports, 20 (19.8%) required hospitalization.
Is Intentional dose omission Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EVOLOCUMAB. However, 101 reports have been filed with the FAERS database.
What Other Side Effects Does EVOLOCUMAB Cause?
Device difficult to use (31,807)
Drug dose omission by device (23,957)
Wrong technique in product usage process (21,664)
Accidental exposure to product (16,160)
Injection site pain (9,988)
Product storage error (6,606)
Back pain (5,254)
Myalgia (5,061)
Drug dose omission (4,914)
Injection site bruising (4,409)
What Other Drugs Cause Intentional dose omission?
DUPILUMAB (2,269)
CERTOLIZUMAB PEGOL (1,253)
ADALIMUMAB (845)
TOFACITINIB (845)
INFLIXIMAB (815)
ABALOPARATIDE (623)
ETANERCEPT (615)
AMBRISENTAN (595)
SODIUM OXYBATE (580)
CALCIUM OXYBATE\MAGNESIUM OXYBATE\POTASSIUM OXYBATE\SODIUM OXYBATE (518)
Which EVOLOCUMAB Alternatives Have Lower Intentional dose omission Risk?
EVOLOCUMAB vs EXELON
EVOLOCUMAB vs EXEMESTANE
EVOLOCUMAB vs EXENATIDE
EVOLOCUMAB vs EXFORGE
EVOLOCUMAB vs EXJADE